Form DEF 14A TuHURA Biosciences For: 9 July
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TuHURA Biosciences Inc (HURA)
Track today's live TuHURA Biosciences (HURA) share price, performance and key data on this page with our current NASDAQ:HURA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the TuHURA Biosciences share price on the NASDAQ exchange. Use the dropdown to switch exchange for the HURA share price, head to our technical summary section, which provides analysis on TuHURA Biosciences share price buy/sell indicators using real-time data (or discuss the TuHURA Biosciences (HURA) stock price today with other investors in the TuHURA Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:HURA share price (ISIN: US8989201038) to enhance your trading decisions with our free investment tools and resources.
What Is the TuHURA Biosciences Inc Share Price Today?
The TuHURA Biosciences share price today is 2.1150.
What Is the Stock Symbol for TuHURA Biosciences Inc
The stock symbol (or 'ticker') for TuHURA Biosciences Inc is "HURA."
What Stock Exchange Does TuHURA Biosciences Inc Trade On?
TuHURA Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is TuHURA Biosciences Inc a Good Stock to Buy?
Determining whether TuHURA Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:HURA share price (ISIN: US8989201038) to enhance your trading decisions with our free investment tools and resources.
What Is the TuHURA Biosciences Inc Share Price Today?
The TuHURA Biosciences share price today is 2.1150.
What Is the Stock Symbol for TuHURA Biosciences Inc
The stock symbol (or 'ticker') for TuHURA Biosciences Inc is "HURA."
What Stock Exchange Does TuHURA Biosciences Inc Trade On?
TuHURA Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is TuHURA Biosciences Inc a Good Stock to Buy?
Determining whether TuHURA Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.0700
2.1500
52 wk Range
0.4100
3.9000
Earnings results expected in 8 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.07002.1500
52 wk Range
0.41003.9000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HURA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
7.5500
Upside
+256.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
TuHURA files IND for TBS-2025 in blood cancer study- Investing.com
Form PRE 14A TuHURA Biosciences For: 26 June- Investing.com
Form 10Q TuHURA Biosciences Inc For: 15 May- Investing.com
- Form DEF 14A TuHURA Biosciences For: 9 July
- Investing.com
- Form PRE 14A TuHURA Biosciences For: 26 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 7.5500
(+256.97% Upside)
Earnings
Latest Release
12/05/2026
EPS / Forecast
-0.13 / -0.09
Revenue / Forecast
-- / --
Compare HURA to Peers and Sector
Metrics to compare | HURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.4x | −4.8x | −0.4x | |
PEG Ratio | −0.12 | 0.04 | 0.00 | |
Price/Book | 5.9x | 1.9x | 2.6x | |
Price / LTM Sales | - | 66.8x | 3.0x | |
Upside (Analyst Target) | 258.9% | 233.4% | 51.8% | |
Fair Value Upside | Unlock | 1.6% | 7.2% | Unlock |
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company’s lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the TuHURA Biosciences (NASDAQ: HURA) Share Price Today?
The TuHURA Biosciences stock price today is 2.1150 USD.
What Stock Exchange Does TuHURA Biosciences (HURA) Trade On?
TuHURA Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for TuHURA Biosciences?
The stock symbol (also called a 'ticker') for TuHURA Biosciences is "HURA."
What Is the Current TuHURA Biosciences Market Capitalisation?
As of today, TuHURA Biosciences (NASDAQ: HURA) market cap is 133.1000M USD.
What Is TuHURA Biosciences's (HURA) Earnings Per Share (TTM)?
The TuHURA Biosciences EPS is currently -0.5940 (Trailing Twelve Months).
When Is the Next TuHURA Biosciences Earnings Date?
TuHURA Biosciences's next earnings report will be released on 14/08/2026.
Is HURA a Buy or Sell From a Technical Analyst Perspective?
Based on today's TuHURA Biosciences moving averages and other technical indicators, the daily buy/sell signal for HURA stock is Strong Sell.
How Many Times Has TuHURA Biosciences Stock Split?
TuHURA Biosciences has split 5 times. (See the HURA stock split history page for full effective split date and price information.)
What is the current trading status of TuHURA Biosciences (NASDAQ: HURA)?
As of 06/08/2026, TuHURA Biosciences (HURA) is trading at a share price of 2.1150 USD, with a previous close of 2.0900 USD. The stock has fluctuated within a day range of 2.0700 USD to 2.1500 USD, while its 52-week range spans from 0.4100 USD to 3.9000 USD.
What Is TuHURA Biosciences (HURA) Price Target According to Analysts?
The average 12-month price target for TuHURA Biosciences is 7.5500 USD, with a high estimate of 9 USD and a low estimate of 6.2 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +256.97% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.